Geriatric Medicine Development - Carving out New Opportunities to Treat Age-related Diseases
Albany, NewYork (PRWEB) April 14, 2014
More than 50% of prescriptions is written for people aged 65 years and older. Many older people suffer from comorbid conditions and one in three takes at least five drugs or more on a daily basis. This significantly increases the risk of Adverse Drug Events (ADEs) and hospitalization. Up to one third of emergency admissions in elderly people is drug-related.
There remains a lack of clinical data to support prescription decisions as relatively few medicines have been clinically evaluated in age-appropriate patients. In addition, many drugs are not available in formulations that are suitable for the elderly, leading to non-compliance and lack of therapeutic efficacy. In 2011, the EMA introduced its Geriatric Medicines Strategy to ensure that the medical requirements of older people are identified earlier in the drug development process. In 2012, the ICH E7 guidelines were revised to include a greater focus on involving more geriatric patients in drug trials.
All Latest Market Research Report @ http://www.researchmoz.us/latest-report.html
Reviews the current regulatory landscape and helps sponsors to understand the potential impact of recent guidelines.
Assesses the barriers to entry in geriatric medicines and identifies potential ways to overcome them and improve clinical decision making.
Evaluates the importance of establishing Target Quality Product Profiles (TQPP) to help sponsors determine the target patient population earlier on in drug development.
Identifies treatment gaps and commercial opportunities based on primary care real-time data and KOL insights.
Analyses different strategies to develop age-appropriate medicines in niche therapeutic fields and discusses methods to encourage the smarter prescription of medicines.
All Countrywise Report @ http://www.researchmoz.us/country.html
Key Reasons to Purchase
Utilize the insights from this study to analyze the barriers facing the geriatrics market
Understand the impact of drug development in this market now and in the future
Find out why regulators are paying more attention to unnecessary “exclusion criteria” and encouraging the inclusion of older people to ensure trials are age-appropriate and more representative of the real world setting.
Assess the opportunities available for companies to develop age-appropriate dosages and formulations for existing drug classes that are currently widely associated with ADEs in the elderly as well as new therapeutic prospects.
China Pharmaceutical Glass Packaging Industry Report, 2013-2016
Due to low entry barriers, (http://www.researchmoz.us/china-pharmaceutical-glass-packaging-industry-report-2013-2016-report.html) Chinese pharmaceutical glass market is featured with serious overcapcity of medium and low-end products as well as the reliance of high-end products on imports. At present, developed countries prefer first-class waterproof neutral borosilicate glass, while China still in the main applies low borosilicate glass, sodium-calcium glass and "semi-neutral borosilicate glass" (its chemical stability can not meet neutral requirements; the heavy metal content in glass is not defined clearly; dimensions are not accurate). As for prefilled injection system glass, China mainly relies on the import from foreign brands such as German Schott.
2014 Market Research Report on Global Berberine Industry
The report firstly introduced Berberine (http://www.researchmoz.us/2014-market-research-report-on-global-berberine-industry-report.html) basic information including Berberine definition classification application and industry chain overview; Berberine industry policy and plan, Berberine product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.In the end, the report introduced Berberine new project SWOT analysis, investment feasibility analysis, and investment return analysis and Global Berberine industry.
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis.We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports.We provide our services to all sizes of organizations and across all industry verticals and markets.Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948